Streetbeat News

Regulatory

INTC

META

MSFT

PFE

TSLA

Intel, Microsoft, Meta Platforms, Pfizer, and Tesla are in focus due to various developments. Intel surged on potential federal funding, Microsoft announced a share buyback and dividend increase, Meta is using UK data for AI, Pfizer faces vaccine safety concerns, and Tesla saw a drop despite increased EV registrations.

Portfolio Pulse from Benzinga Neuro

September 17, 2024 | 2:50 am

NVVE

Trading for NVVE has been halted as of 7:50:00 p.m. ET due to pending news. This indicates that significant information regarding the company is expected to be released soon.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 11:50 pm

TLT

The iShares 20+ Year Treasury Bond ETF (TLT) reached a 14-month high as investors anticipate a Federal Reserve rate cut. The FOMC meeting on Sept. 18 is expected to result in a rate cut, with a 61% chance of a 50-basis-point reduction. Analysts are divided on the size of the cut, with some predicting a smaller 25-basis-point cut.

Portfolio Pulse from Piero Cingari

September 16, 2024 | 8:46 pm

BTCUSD

DOGEUSD

ETHUSD

Cryptocurrency markets, including Bitcoin, Ethereum, and Dogecoin, are experiencing declines ahead of a potential rate cut decision. Bitcoin has broken support levels, with predictions of further drops. Despite this, some analysts see short-term obstacles as beneficial for medium-term growth.

Portfolio Pulse from Khyathi Dalal

September 16, 2024 | 8:43 pm

LUCD

PAVM

PAVmed is taking steps to regain Nasdaq compliance by deconsolidating Lucid Diagnostics from its financials and appointing Sundeep Agrawal to its board. This move increases PAVmed's stockholder equity while maintaining its status as the largest shareholder in Lucid.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 8:32 pm

INTC

Intel shares surged following reports of potential $3 billion federal funding for military chip production under the CHIPS and Science Act. This funding aims to secure a domestic supply of advanced chips for defense purposes. Intel is a frontrunner for these grants, which would enhance its semiconductor production capabilities.

Portfolio Pulse from Vaishali Prayag

September 16, 2024 | 8:14 pm

CMND

Clearmind Medicine has announced the publication of a patent application under the Patent Cooperation Treaty for its ibogaine combination therapy. This development could enhance the company's intellectual property portfolio and potentially lead to new treatment options.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 8:08 pm

NIO

TSLA

The Biden administration has imposed steep tariffs on Chinese goods, including a 100% tax on Chinese-made electric vehicles, to boost U.S. manufacturing and jobs. This move is seen as a response to the growing competition from Chinese automakers and comes ahead of the November elections. Detroit automakers like General Motors and Ford are exploring Chinese technology to enhance their EV offerings, while Tesla's CEO has expressed concerns about the impact of Chinese EVs on the U.S. market.

Portfolio Pulse from Natan Ponieman

September 16, 2024 | 8:06 pm

AVGR

Avinger is set to receive a U.S. patent for a new atherectomy catheter technology aimed at treating occlusive coronary artery disease. This patent could enhance Avinger's product offerings and market position.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 7:59 pm

SNOA

Sonoma Pharmaceuticals' stock is rising following the FDA's 510(k) clearance for its microdacyn wound care solution, indicating potential growth and increased market presence.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 7:39 pm